Compare AGCO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGCO | ELAN |
|---|---|---|
| Founded | 1990 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.3B |
| IPO Year | 1994 | 2018 |
| Metric | AGCO | ELAN |
|---|---|---|
| Price | $137.75 | $24.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $118.73 | $24.89 |
| AVG Volume (30 Days) | 872.9K | ★ 3.9M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ 271.35 | 127.20 |
| EPS | ★ 9.75 | 0.09 |
| Revenue | ★ $10,082,000,000.00 | $4,439,000,000.00 |
| Revenue This Year | $6.67 | $7.25 |
| Revenue Next Year | $5.60 | $5.80 |
| P/E Ratio | ★ $14.13 | $277.56 |
| Revenue Growth | N/A | ★ 0.50 |
| 52 Week Low | $73.80 | $8.02 |
| 52 Week High | $143.78 | $26.08 |
| Indicator | AGCO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 73.90 | 54.88 |
| Support Level | $135.41 | $24.14 |
| Resistance Level | $143.00 | $25.34 |
| Average True Range (ATR) | 4.95 | 0.75 |
| MACD | 0.73 | -0.06 |
| Stochastic Oscillator | 81.26 | 47.75 |
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.